Month: September 2010

Daxor Corporation announces that a second research report derived from a study using the Daxor Blood Volume Analyzer (BVA-100) was presented at the annual Heart Failure Society of America (HFSA) conference.

Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical urine drug monitoring assays to detect the metabolites of JWH-018 and JWH-073, two compounds typically found in synthetic cannabinoids.

Clinical and Laboratory Standards Institute (CLSI) recently published a document, “Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline — Second Edition” (M45-A2).

At the first sign of a disease pandemic, public health officials should begin strongly communicating about the extent of the outbreak and the steps that can be taken by the public to avoid infection.